Private equity firms don't care about your health scores or QBRs. They care about one question: what makes this business worth more tomorrow than it is today.

Carlos Granda spent 30 years running post-sales at Google Cloud, Salesforce, SAP, and Oracle before he started advising the private equity firms buying up software companies. That vantage point gave him a name for a problem most executives never see coming: the GRR time bomb. A healthy net revenue retention number can hide real churn underneath it, and by the time anyone notices, the damage is already baked into the company's valuation.

Why do so many leaders celebrate 103% NRR without asking what they lost to get there? Carlos breaks down the math and makes the case that gross revenue retention, not NRR, is the number that actually tells the truth.

He also pushes back on a phrase every account manager has heard a hundred times: "it's too expensive." That's rarely the real reason a customer leaves, and Carlos explains what's usually hiding underneath it. His bigger argument is that post-sales professionals are underappreciated because most of them have never learned to translate their work into the language of enterprise value. What would change on your team if a support ticket and a churn risk were understood as the same conversation PE firms are already having about your company's worth?

Episode Breakdown:

00:00 Why Private Equity Cares About Enterprise Value, Not Health Scores

06:48 Connecting Account Management to Enterprise Value Creation

16:04 What Private Equity Firms Actually Evaluate in Post-Sales Teams

20:02 NRR vs GRR: The Metric That Tells the Truth

27:04 Building a GRR Get Well Plan

34:43 How to Pitch the Same Initiative to a CEO vs a PE Firm

44:11 The Future of Post-Sales: AI and the Disappearing Line Between Sales and Support

Connect with Carlos Granda:

Connect with Carlos on LinkedIn

Connect with Alex Raymond:

Connect with Alex on LinkedIn

Visit the AMplify website

Podcast production and show notes provided by HiveCast.fm